DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE 20 g/100mL
Niacinamide · LIQUID · LAON COMMERCE co ltd
DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE is a liquid containing niacinamide at 20 g/100mL, taken topical. Manufactured by LAON COMMERCE co ltd.
Key Facts
- Brand Name
- DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE
- Generic Name
- Niacinamide
- NDC Code (Product)
82083-0028- Manufacturer
- LAON COMMERCE co ltd
- Strength
- 20 g/100mL
- Dosage Form
- LIQUID
- Route
- TOPICAL
- Marketing Status
- Marketing Start
- 12/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE used for?
DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE contains Niacinamide. It is a liquid taken topical. Consult your doctor for specific uses.
Is DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE a controlled substance?
DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE is not classified as a controlled substance by the DEA.
What is the generic name for DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE?
The generic name for DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE is Niacinamide. There are 12 other brand versions of Niacinamide.
What is the NDC code for DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE 20 g/100mL?
The NDC (National Drug Code) for DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE 20 g/100mL is 82083-0028, listed by LAON COMMERCE co ltd.
Other Niacinamide Brands
See all →- by Selected Repair Vitality.02 g/50mL73509-040
- Dr. sunmi care Duel Hyaluronic Acid Essence.04 g/100mL82083-0020
- Atti amour Rose Anti-Aging Repair Serum5.96 g/100mL84601-002
- THE SKIN HOUSE Vital BrightEmulsion1 g/100mL73590-0050
- COXIR INTENSIVE EGF PEPTIDE TONER.06 g/150mL73590-0074
- DERMAHAN THE WHITENING MOISTURIZING MASK2 g/100g82083-0003
- Dr.Jucre Rebirth Eye.04 g/100mL83071-120
- DERLADIE WITCH HAZEL PERFECT VITAMIN SERUM.04 g/100mL82083-0002
- DERLADIE HerbalExtract BodySolution MIST3 g/100mL82083-0023
- TURMERICFaceCream100 mg/g84019-025
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)